{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:04:21Z","timestamp":1781042661582,"version":"3.54.1"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":42,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ctarc.2021.100336","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T15:11:21Z","timestamp":1613401881000},"page":"100336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Appetite problem in cancer patients: Pathophysiology, diagnosis, and treatment"],"prefix":"10.1016","volume":"27","author":[{"given":"Timotius Ivan","family":"Hariyanto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andree","family":"Kurniawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ctarc.2021.100336_bib0001","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpainsymman.2006.05.012","article-title":"The prevalence of concern about weight loss and change in eating habits in people with advanced cancer","volume":"32","author":"Hopkinson","year":"2006","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"10.1016\/j.ctarc.2021.100336_bib0002","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1191\/0269216302pm593oa","article-title":"Loss of weight and loss of appetite in advanced cancer: a problem for the patient, the carer, or the health professional?","volume":"16","author":"Poole","year":"2002","journal-title":"Palliat Med"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100336_bib0003","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1207\/S15327914NC352_5","article-title":"Longitudinal study of weight, appetite, performances status and inflammation in advanced gastrointestinal cancer","volume":"35","author":"O\u2019Gorman","year":"1999","journal-title":"Nutr Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2021.100336_bib0004","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","article-title":"Cachexia in cancer patients","volume":"2","author":"Tisdale","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"25","key":"10.1016\/j.ctarc.2021.100336_bib0005","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1200\/JCO.2005.06.866","article-title":"Prognotic factors of advanced cancer patients: evidence-based clinical recommendations- a study by the steering committee of the European association for palliative care","volume":"23","author":"Maltoni","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100336_bib0006","first-page":"377","article-title":"The functional assessment of anorexia\/cachexia therapy (FAACT) appetite scale in veteran cancer patients.","volume":"3","author":"Chang","year":"2005","journal-title":"J Support Oncol"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100336_bib0007","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1677\/joe.1.05866","article-title":"Appetite control.","volume":"184","author":"Wynne","year":"2005","journal-title":"J Endocrinol."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100336_bib0008","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0896-6273(02)00969-8","article-title":"The need to feed: homeostatic and hedonic control of eating","volume":"36","author":"Saper","year":"2002","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100336_bib0009","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1113\/expphysiol.2004.027789","article-title":"Gut hormones in the control of appetite","volume":"89","author":"Murphy","year":"2004","journal-title":"Exp Physiol"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100336_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yfrne.2003.10.001","article-title":"Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance","volume":"24","author":"Sahu","year":"2003","journal-title":"Front Neuroendocrinol"},{"issue":"11","key":"10.1016\/j.ctarc.2021.100336_bib0011","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1210\/en.2007-0543","article-title":"Impaired central insulin response in aged Wistar rats: role of adiposity","volume":"148","author":"Garc\u00eda-San Frutos","year":"2007","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0012","first-page":"68","article-title":"Interacting appetite-regulating pathways in the hypothalamic regulation of body weight","volume":"20","author":"Kalra","year":"1999","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0013","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.2000.278.1.E1","article-title":"The adipoinsular axis: effects of leptin on pancreatic beta-cells","volume":"278","author":"Kieffer","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6762","key":"10.1016\/j.ctarc.2021.100336_bib0014","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ctarc.2021.100336_bib0015","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/diabetes.50.11.2540","article-title":"Ghrelin causes hyperphagia and obesity in rats","volume":"50","author":"Wren","year":"2001","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100336_bib0016","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000054491","article-title":"Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat","volume":"70","author":"Willesen","year":"1999","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0017","doi-asserted-by":"crossref","first-page":"G126","DOI":"10.1152\/ajpgi.2000.279.1.G126","article-title":"Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity","volume":"279","author":"Keire","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0018","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1038\/nutd.2011.21","article-title":"Appetite regulation and weight control: the role of gut hormones","volume":"2","author":"Perry","year":"2012","journal-title":"Nutr Diabetes"},{"issue":"8571","key":"10.1016\/j.ctarc.2021.100336_bib0019","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7-36: a physiological incretin in man","volume":"2","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ctarc.2021.100336_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/379069a0","article-title":"A role for glucagon-like peptide-1 in the central regulation of feeding","volume":"379","author":"Turton","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2021.100336_bib0021","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2337\/dc06-2593","article-title":"Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes","volume":"30","author":"Vilsboll","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ctarc.2021.100336_bib0022","first-page":"427","article-title":"Cancer anorexia-cachexia syndrome: cytokines and neuropeptides","volume":"7","author":"Ramos","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100336_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213602","article-title":"Plasma cytokine levels and the presence of colorectal cancer","volume":"14","author":"Yamaguchi","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ctarc.2021.100336_bib0024","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3390\/ijms20081831","article-title":"Reduced T-cell numbers and elevated levels of immunomodulatory cytokines in metastatic prostate cancer patients de novo resistant to abiraterone and\/or enzalutamide therapy","volume":"20","author":"Pal","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ctarc.2021.100336_bib0025","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cca.2011.12.008","article-title":"Integrative role of neuropeptides and cytokines in cancer anorexia-cachexia syndrome.","volume":"413","author":"Patra","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100336_bib0026","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/cyto.2002.0890","article-title":"HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion","volume":"18","author":"Agnello","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.ctarc.2021.100336_bib0027","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.mco.0000134373.16557.92","article-title":"Interleukin-1b system in anorectic catabolic tumor bearing rats. Cytokine, Neuropeptide and G Protein alpha-subunit mRNAs in Anorectic MCA Tumor Bearing Rats","volume":"4","author":"Turrin","year":"2004","journal-title":"Curr Opin Clin Nutr"},{"key":"10.1016\/j.ctarc.2021.100336_bib0028","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbi.2019.07.017","article-title":"Interleukin-1 reduces food intake and body weight in rat by acting in the arcuate hypothalamus.","volume":"81","author":"Chaskiel","year":"2019","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.ctarc.2021.100336_bib0029","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/1049909108315518","article-title":"Cytokines and cancer anorexia cachexia syndrome","volume":"25","author":"Bennani-Baiti","year":"2008","journal-title":"Am J Hospice Pall Med"},{"key":"10.1016\/j.ctarc.2021.100336_bib0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/1098-240X(200006)23:3<222::AID-NUR6>3.0.CO;2-3","article-title":"Tumor necrosis factor alpha and interleukin-6 have differential effect on food intake and gastric emptying in fasted rats.","volume":"23","author":"McCarthy","year":"2000","journal-title":"Res Nurs Health"},{"issue":"40","key":"10.1016\/j.ctarc.2021.100336_bib0031","doi-asserted-by":"crossref","first-page":"16199","DOI":"10.1073\/pnas.1306799110","article-title":"Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6","volume":"110","author":"Shirazi","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.ctarc.2021.100336_bib0032","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.peptides.2007.03.006","article-title":"TNF-a acts in the hypothalamus inhibiting food intake and increasing the respiratory quotient\u2014Effects on leptin and insulin signaling pathways","volume":"28","author":"Romanatto","year":"2007","journal-title":"Peptides"},{"issue":"10","key":"10.1016\/j.ctarc.2021.100336_bib0033","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0899-9007(00)00413-5","article-title":"Central nervous system mechanism contributing to the cachexia-anorexia syndrome","volume":"16","author":"Plata-Salaman","year":"2000","journal-title":"Nutrition"},{"key":"10.1016\/j.ctarc.2021.100336_bib0034","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcp.22196","article-title":"Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer","volume":"224","author":"Mimeault","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0035","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1053\/j.gastro.2006.09.015","article-title":"Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia","volume":"131","author":"Baek","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctarc.2021.100336_bib0036","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm1677","article-title":"Tumor-induced anorexia and weight loss are mediated by the TGF-b superfamily cytokine MIC-1.","volume":"13","author":"Johnen","year":"2007","journal-title":"Nat Med"},{"issue":"15 suppl.","key":"10.1016\/j.ctarc.2021.100336_bib0037","article-title":"Effect of growth differentiation factor 15 (GDF-15) inhibition on energy balance in cancer cachexia and in lipopolysaccharide (LPS)-induced sepsis mouse models","volume":"38","author":"Breen","year":"2020","journal-title":"J. Clin. Oncol"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100336_bib0038","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3892\/ol.2016.5183","article-title":"Growth differentiating factor-15 (GDF-15): a potential biomarker and therapeutic target for cancer-associated weight loss","volume":"12","author":"Lerner","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ctarc.2021.100336_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh186","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Takeda","year":"2005","journal-title":"Int Immunol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0040","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nri3713","article-title":"Assembly and localization of Toll-like receptor signalling complexes.","volume":"14","author":"Gay","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.ctarc.2021.100336_bib0041","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/archotol.133.12.1263","article-title":"The effect of altered Toll-like receptor 4 signaling on cancer cachexia","volume":"133","author":"Cannon","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ctarc.2021.100336_bib0042","doi-asserted-by":"crossref","first-page":"R298","DOI":"10.1152\/ajpregu.00659.2003","article-title":"Role for CD14, TLR2, and TLR4 in bacterial product-induced anorexia","volume":"287","author":"von Meyenburg","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0043","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41598-017-02347-2","article-title":"Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctarc.2021.100336_bib0044","doi-asserted-by":"crossref","first-page":"35813","DOI":"10.1038\/srep35813","article-title":"A role for intestinal TLR4-driven inflammatory response during activity-based anorexia","volume":"6","author":"Belmonte","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctarc.2021.100336_bib0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fimmu.2014.00070","article-title":"Beyond MyD88 and TRIF pathways in Toll-Like Receptor signaling","volume":"5","author":"Piras","year":"2014","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ctarc.2021.100336_bib0046","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1210\/en.2006-0465","article-title":"MyD88 is a key mediator of anorexia, but not weight loss, induced by lipopolysaccharide and interleukin-1\u03b2.","volume":"147","author":"Ogimoto","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ctarc.2021.100336_bib0047","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bbi.2010.01.006","article-title":"Deletion of the gene encoding MyD88 protects from anorexia in mouse tumor model.","volume":"24","author":"Ruud","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ctarc.2021.100336_bib0048","doi-asserted-by":"crossref","first-page":"R403","DOI":"10.1152\/ajpregu.00395.2009","article-title":"MyD88 plays a key role in LPS-induced Stat3 activation in the hypothalamus","volume":"298","author":"Yamawaki","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0049","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1096\/fj.12-225433","article-title":"Inflammation- and tumor-induced anorexia and weight loss require MyD88 in hematopoietic\/myeloid cells but not in brain endothelial or neural cells","volume":"27","author":"Ruud","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.ctarc.2021.100336_bib0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbi.2018.05.021","article-title":"TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia","volume":"73","author":"Burfeind","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ctarc.2021.100336_bib0051","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2006.08.012","article-title":"Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice","volume":"81","author":"Quennet","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0052","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature24057","article-title":"Glucose feeds the TCA cycle via circulating lactate","volume":"551","author":"Hui","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2021.100336_bib0053","first-page":"125","article-title":"Elevated lactate and total protein levels in stereotactic brain biopsy specimen: potential biomarkers of malignancy and poor prognosis","volume":"22","author":"Nikoobakht","year":"2019","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.ctarc.2021.100336_bib0054","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/CBM-150514","article-title":"Elevated lactic acid is a negative prognostic factor in metastatic lung cancer","volume":"15","author":"Vlachostergios","year":"2015","journal-title":"Cancer Biomarkers"},{"key":"10.1016\/j.ctarc.2021.100336_bib0055","doi-asserted-by":"crossref","first-page":"e13151","DOI":"10.1097\/MD.0000000000013151","article-title":"Prognostic value of pretreatment serum lactate dehydrogenase level in pancreatic cancer patients","volume":"97","author":"Gan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ctarc.2021.100336_bib0056","doi-asserted-by":"crossref","first-page":"R646","DOI":"10.1152\/ajpregu.2000.278.3.R646","article-title":"Prandial lactate infusion inhibits spontaneous feeding in rats","volume":"278","author":"Silberbauer","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0057","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2826.2004.01185.x","article-title":"Acute Intracarotid glucose injection towards the brain induces specific c-fos activation in hypothalamic nuclei: involvement of astrocytes in cerebral glucose-sensing in rats","volume":"16","author":"Guillod-Maximin","year":"2004","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0058","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1111\/j.1582-4934.2008.00596.x","article-title":"Hypothalamic sensing of circulating lactate regulates glucose production","volume":"13","author":"Kokorovic","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ctarc.2021.100336_bib0059","doi-asserted-by":"crossref","first-page":"E491","DOI":"10.1152\/ajpendo.90481.2008","article-title":"Central lactate metabolism regulates food intake","volume":"295","author":"Lam","year":"2008","journal-title":"Am J PHysiol Endocrionl Metab"},{"key":"10.1016\/j.ctarc.2021.100336_bib0060","doi-asserted-by":"crossref","first-page":"e62532","DOI":"10.1371\/journal.pone.0062532","article-title":"MCT2 expression and lactate influx in anorexigenic and orexigenic neurons of the arcuate nucleus","volume":"8","author":"Cortes-Campos","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ctarc.2021.100336_bib0061","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.appet.2012.01.022","article-title":"Lactate infusion during euglycemia but not hypoglycemia reduces subsequent food intake in healthy men.","volume":"58","author":"Schultes","year":"2012","journal-title":"Appetite"},{"key":"10.1016\/j.ctarc.2021.100336_bib0062","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/089686080902900611","article-title":"Bicarbonate-based periotoneal dialysis solution has less effect on ingestive behavior than lactate-based peritoneal dialysis solution","volume":"29","author":"Zheng","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.ctarc.2021.100336_bib0063","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbrc.2009.06.017","article-title":"Central lactate metabolism suppresses food intake via the hypothalamic AMP kinase\/malonyl-CoA signaling pathway","volume":"386","author":"Cha","year":"2009","journal-title":"Biochem Biophys Res Communic"},{"key":"10.1016\/j.ctarc.2021.100336_bib0064","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmet.2007.09.012","article-title":"Serotonin and the orchestration of energy balance","volume":"6","author":"Tecott","year":"2007","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100336_bib0065","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/pros.10374","article-title":"Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines","volume":"59","author":"Dizeyi","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.ctarc.2021.100336_bib0066","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1038\/s41598-017-15832-5","article-title":"Serotonin regulates prostate growth through androgen receptor modulation","volume":"7","author":"Carvalho-Dias","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.ctarc.2021.100336_bib0067","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2217\/fon-2018-0960","article-title":"Serotonin levels and 1-year mortality in patients with neuroendocrine tumors: a systematic review and meta-analysis.","volume":"15","author":"Joish","year":"2019","journal-title":"Fut Oncol"},{"issue":"28","key":"10.1016\/j.ctarc.2021.100336_bib0068","doi-asserted-by":"crossref","first-page":"25975","DOI":"10.18632\/oncotarget.4543","article-title":"5-hydroxytryptamine receptor (5-HT1DR) promotes colorectal cancer metastasis by regulating Axin1\/\u03b2-catenin\/MMP-7 signaling pathway","volume":"6","author":"Sui","year":"2015","journal-title":"Oncotarget"},{"issue":"21","key":"10.1016\/j.ctarc.2021.100336_bib0069","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1002\/cncr.24533","article-title":"Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines","volume":"115","author":"Drozdov","year":"2009","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.ctarc.2021.100336_bib0070","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1158\/1078-0432.CCR-11-1813","article-title":"Expression of serotonin receptors in human hepatocellular cancer","volume":"18","author":"Soll","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctarc.2021.100336_bib0071","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12868-016-0260-0","article-title":"Increased hypothalamic serotonin turnover in inflammation-induced anorexia","volume":"17","author":"Dwarkasing","year":"2016","journal-title":"BMC Neurosci"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(01)03305-4","article-title":"Anorexia in a rat model of colitis: interaction of interleukin-1 and hypothalamic serotonin.","volume":"927","author":"El-Haj","year":"2002","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0073","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jcsm.12008","article-title":"Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signalling","volume":"6","author":"Dwarkasing","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ctarc.2021.100336_bib0074","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.neulet.2005.04.031","article-title":"Normalization of hypothalamic serotonin (5-HT1B) receptor and NPY in cancer after tumor resection: an immunocytochemical study.","volume":"383","author":"Makarenko","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.ctarc.2021.100336_bib0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01245044","article-title":"Plasma and CSF tryptophan in cancer anorexia.","volume":"81","author":"Cangiano","year":"1990","journal-title":"J Neural Transm Gen Sect"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100336_bib0076","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.neuron.2008.09.033","article-title":"5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis","volume":"60","author":"Xu","year":"2008","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100336_bib0077","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.peptides.2004.01.012","article-title":"Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus.","volume":"25","author":"Meguid","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.ctarc.2021.100336_bib0078","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuron.2006.06.004","article-title":"Serotonin reciprocally regulates melanocortin neurons to modulate food intake","volume":"51","author":"Heisler","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.ctarc.2021.100336_bib0079","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1016\/j.ejim.2009.05.012","article-title":"Unraveling the science of incretin biology","volume":"20","author":"Nauck","year":"2009","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.ctarc.2021.100336_bib0080","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.molmet.2017.04.007","article-title":"The endogenous preproglucagon system is not essential for gut growth homeostasis in mice","volume":"6","author":"Wismann","year":"2017","journal-title":"Mol Metab"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100336_bib0081","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/en.2018-00004","article-title":"GLP-1 receptor expression within the human heart","volume":"159","author":"Baggio","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.ctarc.2021.100336_bib0082","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000330447","article-title":"Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: relevance for incretin-based diabetes therapy.","volume":"94","author":"Waser","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ctarc.2021.100336_bib0083","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","article-title":"Concomitant expression of several peptide receptors in neuroendocrine tumors as molecular basis for in vivo multireceptor tumor targeting","volume":"30","author":"Reubi","year":"2003","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.ctarc.2021.100336_bib0084","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2967\/jnumed.106.038679","article-title":"GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting","volume":"48","author":"Korner","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ctarc.2021.100336_bib0085","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/en.2008-1221","article-title":"Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms","volume":"150","author":"Ruttimann","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ctarc.2021.100336_bib0086","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1210\/en.2013-1447","article-title":"Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance","volume":"155","author":"Punjabi","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.ctarc.2021.100336_bib0087","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.physbeh.2010.02.029","article-title":"Role of the glucagon-likepeptide-1 receptor in the control of energy balance","volume":"100","author":"Hayes","year":"2010","journal-title":"Physiol Behav"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100336_bib0088","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.physbeh.2012.02.017","article-title":"Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects.","volume":"106","author":"Hayes","year":"2012","journal-title":"Physiol Behav"},{"key":"10.1016\/j.ctarc.2021.100336_bib0089","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2017.12.024","article-title":"Brainstem GLP-1 signalling contributes to cancer anorexia-cachexia syndrome in the rat.","volume":"131","author":"Borner","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ctarc.2021.100336_bib0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2011.02.001","article-title":"Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation","volume":"13","author":"Hayes","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.ctarc.2021.100336_bib0091","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.physbeh.2010.02.029","article-title":"Role of the glucagon-like-peptide-1 receptor in the control of energy balance","volume":"100","author":"Hayes","year":"2010","journal-title":"Physiol Behav"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100336_bib0092","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"issue":"41","key":"10.1016\/j.ctarc.2021.100336_bib0093","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1523\/JNEUROSCI.3262-11.2011","article-title":"Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake","volume":"31","author":"Dossat","year":"2011","journal-title":"J Neurosci"},{"issue":"5\u20136","key":"10.1016\/j.ctarc.2021.100336_bib0094","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","article-title":"The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide","volume":"62","author":"Kanoski","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ctarc.2021.100336_bib0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/dom.12423","article-title":"Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms.","volume":"17","author":"Kanoski","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ctarc.2021.100336_bib0096","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.2337\/db06-0730","article-title":"Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.","volume":"55","author":"Chelikani","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ctarc.2021.100336_bib0097","doi-asserted-by":"crossref","first-page":"R945","DOI":"10.1152\/ajpregu.00275.2010","article-title":"Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates","volume":"299","author":"Bello","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100336_bib0098","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/db16-0755","article-title":"Glucagon-like peptide 1 and its analogs act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight","volume":"66","author":"Anderberg","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.ctarc.2021.100336_bib0099","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1210\/js.2018-00246","article-title":"Current understanding of the role of nesfatin-1","volume":"2","author":"Schalla","year":"2018","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1756-9966-32-56","article-title":"Clinical significance of NUCB2 mRNA expression in prostate cancer","volume":"32","author":"Zhang","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"issue":"21","key":"10.1016\/j.ctarc.2021.100336_bib0101","doi-asserted-by":"crossref","first-page":"31336","DOI":"10.18632\/oncotarget.9140","article-title":"Nesfatin-1\/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1\/AMPK\/TORC1\/ZEB1 pathways in colon cancer","volume":"7","author":"Kan","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100336_bib0102","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/his.12587","article-title":"Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma","volume":"66","author":"Qi","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.ctarc.2021.100336_bib0103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2017.09.024","article-title":"Activity-based anorexia activates nesfatin-1 immunoreactive neurons in distinct brain nuclei of female rats.","volume":"1677","author":"Scharner","year":"2017","journal-title":"Brain Res"},{"key":"10.1016\/j.ctarc.2021.100336_bib0104","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature05162","article-title":"Identification of nesfatin-1 as a satiety molecule in the hypothalamus","volume":"443","author":"Oh","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100336_bib0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2009.09.002","article-title":"Nesfatin-1 regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway","volume":"10","author":"Maejima","year":"2009","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100336_bib0106","first-page":"661","article-title":"The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A\/CS and the VAS for appetite","volume":"24","author":"Blauwhoff-Buskermolen","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctarc.2021.100336_bib0107","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jpainsymman.2012.06.007","article-title":"Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review.","volume":"45","author":"Oldenmenger","year":"2013","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100336_bib0108","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jpainsymman.2016.10.370","article-title":"The edmonton symptom assessment system 25 years later: past, present, and future developments","volume":"53","author":"Hui","year":"2017","journal-title":"J Pain Symptom Manage"},{"issue":"10","key":"10.1016\/j.ctarc.2021.100336_bib0109","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/JCO.2012.43.6766","article-title":"Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial","volume":"31","author":"Fabbro","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0110","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s11136-019-02135-7","article-title":"Comprehensive validation of the functional assessment of anorexia\/cachexia therapy (FAACT) anorexia\/cachexia subscale (A\/CS) in lung cancer patients with involuntary weight loss","volume":"28","author":"Gelhorn","year":"2019","journal-title":"Qual Life Res"},{"issue":"10","key":"10.1016\/j.ctarc.2021.100336_bib0111","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1016670403148","article-title":"Re-validation and shortening of the Functional Assessment of Anorexia\/Cachexia Therapy (FAACT) questionnaire","volume":"9","author":"Ribaudo","year":"2000","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ctarc.2021.100336_bib0112","first-page":"2341","article-title":"Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS)","volume":"23","author":"LeBlanc","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctarc.2021.100336_bib0113","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ctarc.2021.100336_bib0114","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) cachexia-anorexia in chronic wasting diseases and nutrition in geriatrics","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ctarc.2021.100336_bib0115","first-page":"3","article-title":"FAACT-Anorexia cachexia scale: cutoff value for anorexia diagnosis in advanced non-small cell lung cancer patients","volume":"71","author":"Turcott","year":"2018","journal-title":"Nutr Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2021.100336_bib0116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224540","article-title":"Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer","volume":"14","author":"Abraham","year":"2019","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100336_bib0117","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00003495-200161040-00004","article-title":"Managing cancer-related anorexia\/cachexia.","volume":"61","author":"Mantovani","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.ctarc.2021.100336_bib0118","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.nut.2008.06.020","article-title":"Cachexia and neuropeptide Y.","volume":"24","author":"Morley","year":"2008","journal-title":"Nutrition"},{"key":"10.1016\/j.ctarc.2021.100336_bib0119","first-page":"179","article-title":"The science of megestrol acetate delivery","volume":"19","author":"Femia","year":"2012","journal-title":"Bio Drugs"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100336_bib0120","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome.","author":"Ruiz","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100336_bib0121","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.critrevonc.2013.07.015","article-title":"Clinical evaluation and optimal management of cancer cachexia","volume":"88","author":"Tuca","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0122","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1470-2045(14)71154-4","article-title":"Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomized, placebo-controlled, double-blind trials","volume":"16","author":"Garcia","year":"2015","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100336_bib0123","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/fon.14.14","article-title":"Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome","volume":"10","author":"Currow","year":"2014","journal-title":"Future Oncol"},{"issue":"20","key":"10.1016\/j.ctarc.2021.100336_bib0124","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2217\/fon-2017-0141","article-title":"The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.","volume":"13","author":"Currow","year":"2017","journal-title":"Future Oncol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0125","first-page":"129","article-title":"Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicentre, randomized, double-blind, crossover, pilot study.","volume":"21","author":"Garcia","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctarc.2021.100336_bib0126","first-page":"3495","article-title":"Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial","volume":"24","author":"Takayama","year":"2016","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100336_bib0127","first-page":"1651","article-title":"Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta analysis","volume":"25","author":"Bai","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctarc.2021.100336_bib0128","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2147\/DDDT.S110131","article-title":"Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy","volume":"11","author":"Graf","year":"2017","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100336_bib0129","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1089\/jpm.2006.9.802","article-title":"Cannabinoids in the treatment of symptoms in cancer and AIDS #93","volume":"9","author":"Wilner","year":"2006","journal-title":"J Palliat Med"},{"issue":"6","key":"10.1016\/j.ctarc.2021.100336_bib0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/cpt.108","article-title":"Cannabis in cancer care","volume":"97","author":"Abrams","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.ctarc.2021.100336_bib0131","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","article-title":"Cannabinoids as novel anti-inflammatory drugs","volume":"1","author":"Nagarkatti","year":"2009","journal-title":"Future Med Chem"},{"key":"10.1016\/j.ctarc.2021.100336_bib0132","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2147\/TCRM.S126849","article-title":"Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer","volume":"14","author":"Badowski","year":"2018","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0133","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00482-015-0087-0","article-title":"Wirksamkeit, Vertr\u00e4glichkeit und Sicherheit von Cannabinoiden in der Gastroenterologie","volume":"30","author":"Volz","year":"2016","journal-title":"Der Schmerz"},{"issue":"24","key":"10.1016\/j.ctarc.2021.100336_bib0134","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100336_bib0135","first-page":"137","article-title":"Established and potential therapeutic applications of cannabinoids in oncology","volume":"11","author":"Walsh","year":"2003","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0136","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0165-5728(00)00298-8","article-title":"Molecular mechanisms and Th1\/Th2 pathways in corticosteroid regulation of cytokine production","volume":"109","author":"Kovalovsky","year":"2000","journal-title":"J Neuroimmunol"},{"issue":"9","key":"10.1016\/j.ctarc.2021.100336_bib0137","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1210\/en.2008-0229","article-title":"Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats","volume":"149","author":"Shimizu","year":"2008","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ctarc.2021.100336_bib0138","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1210\/en.2013-1632","article-title":"Glucocorticoids increase NPY gene expression via hypothalamic AMPK signaling in broiler","volume":"155","author":"Liu","year":"2014","journal-title":"chicks.Endocrinology."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100336_bib0139","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1089\/jpm.2013.0324","article-title":"Use of corticosteroids for anorexia in palliative medicine: a systematic review","volume":"17","author":"Miller","year":"2014","journal-title":"J Palliat Med"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100336_bib0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0269216308101486","article-title":"The existential impact of starting corticosteroid treatment as symptom control in advanced metastatic cancer","volume":"23","author":"Lundstr\u00f6m","year":"2009","journal-title":"Palliat Med"},{"key":"10.1016\/j.ctarc.2021.100336_bib0141","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1200\/JCO.2013.54.3926","article-title":"Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial","volume":"32","author":"Paulsen","year":"2014","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ctarc.2021.100336_bib0142","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1200\/JCO.1999.17.10.3299","article-title":"Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia\/cachexia","volume":"17","author":"Loprinzi","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0143","first-page":"351","article-title":"Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects","volume":"16","author":"Kast","year":"2007","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0144","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/TPSY.TPSY_3_19","article-title":"Antidepressant therapy in patients with cancer: a clinical review","volume":"33","author":"Chang","year":"2019","journal-title":"Taiwan J Psychiatry"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100336_bib0145","first-page":"1","article-title":"A review of the use of mirtazapine in cancer patients","volume":"25","author":"Zaini","year":"2016","journal-title":"Malaysian J Psychiatry EJournal"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0146","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1440-1819.2007.01778.x","article-title":"Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression","volume":"62","author":"Kim","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100336_bib0147","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1049909109345685","article-title":"Phase II trial of mirtazapine for cancer-related cachexia and anorexia","volume":"27","author":"Riechelmann","year":"2010","journal-title":"Am J Hosp Palliat Care"},{"issue":"suppl_5","key":"10.1016\/j.ctarc.2021.100336_bib0148","first-page":"v851","article-title":"Mirtazapine in cancer-associated anorexia cachexia: a randomised, double-blind, placebo-controlled trial","volume":"30","author":"Hunter","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0149","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide","volume":"363","author":"Franks","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpainsymman.2011.03.007","article-title":"A Phase II dose titration study of thalidomide for cancer-associated anorexia","volume":"43","author":"Davis","year":"2012","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100336_bib0151","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","article-title":"Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia","volume":"15","author":"Mantovani","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.ctarc.2021.100336_bib0152","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000346446","article-title":"Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide","volume":"58","author":"Wen","year":"2012","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ctarc.2021.100336_bib0153","article-title":"Thalidomide for managing cancer cachexia.","volume":"4","author":"Reid","year":"2012","journal-title":"Cochrane Database Syst. Rev"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100336_bib0154","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.critrevonc.2005.01.004","article-title":"Fish oil, lean tissue, and cancer: is there a role for eicosapentaenoic acid in treating the cancer anorexia\/weight loss syndrome?","volume":"55","author":"Jatoi","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ctarc.2021.100336_bib0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.appet.2013.02.019","article-title":"Fish oil-supplementation increases appetite in healthy adults. A randomized controlled cross-over trial","volume":"66","author":"Damsbo-Svendsen","year":"2013","journal-title":"Appetite"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100336_bib0156","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.nut.2014.12.002","article-title":"Eicosapentaenoic acid in cancer improves body composition and modulates metabolism","volume":"31","author":"Pappalardo","year":"2015","journal-title":"Nutrition"},{"issue":"6","key":"10.1016\/j.ctarc.2021.100336_bib0157","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.clnu.2014.03.006","article-title":"Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial","volume":"33","author":"S\u00e1nchez-Lara","year":"2014","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100336_bib0158","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0040-1713701","article-title":"Cachexia in Cancer Patients: systematic Literature Review","volume":"6","author":"Hariyanto","year":"2020","journal-title":"Asian J. Oncol"},{"issue":"12","key":"10.1016\/j.ctarc.2021.100336_bib0159","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1200\/JCO.2004.06.024","article-title":"An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort","volume":"22","author":"Jatoi","year":"2004","journal-title":"J Clin Oncol"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:26:47Z","timestamp":1762842407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294221000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":159,"alternative-id":["S2468294221000356"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100336","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appetite problem in cancer patients: Pathophysiology, diagnosis, and treatment","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100336"}}